Publications
|
Sarkar S, Deiter C, Kyle JE, Guney MA, Sarbaugh D, Yin R, Li X, Cui Y, Ramos-Rodriguez M, Nicora CD, Syed F, Juan-Mateu J, Muralidharan C, Pasquali L, Evans-Molina C, Eizirik DL, Webb-Robertson BJM, Burnum-Johnson K, Orr G, Laskin J, Metz TO, Mirmira RG, Sussel L, Ansong C, Nakayasu ES. Regulation of ß-cell death by ADP-ribosylhydrolase ARH3 via lipid signaling in insulitis. Cell Communication and Signaling 2024; 22(1). |
|
Fontcuberta-Pisunyer M, Garcia-Alaman A, Prades E, Tellez N, Alves-Figueiredo H, Ramos-Rodriguez M, Enrich C, Fernandez-Ruiz R, Cervantes S, Clua L, Ramon-Azcon J, Broca C, Wojtusciszyn A, Montserrat N, Pasquali L, Novials A, Servitja JM, Vidal J, Gomis R, Gasa R. Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors. Communications Biology 2023; 6(1). |
|
Corujo D.; Malinverni R.; Carrillo-Reixach J.; Meers O.; Garcia-Jaraquemada A.; Le Pannerer M.M.; Valero V.; Perez A.; Del Rio-Alvarez A.; Royo L.; Perez-Gonzalez B.; Raurell H.; Acemel R.D.; Santos-Pereira J.M.; Garrido-Pontnou M.; Gomez-Skarmeta J.L.; Pasquali L.; Manye J.; Armengol C.; Buschbeck M.. MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines. Cell Reports 2022; 39(12). |
|
Arroyo N, Villamayor L, Díaz I, Carmona R, Ramos-Rodríguez M, Muñoz-Chápuli R, Pasquali L, Toscano MG, Martín F, Cano DA, Rojas A. GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells. JCI Insight 2021; 6(23). |
|
Ramos-Rodríguez M, Pérez-González B, Pasquali L. The ß-cell genomic landscape in T1D: implications for disease pathogenesis. Current Diabetes Reports 2021; 21(1). |
|
Ling C, Pasquali L. Epigenetics in type 2 diabetes. In: Florez, Jose C. (Ed.). Biology, Physiology and Translation The Genetics of Type 2 Diabetes and Related Traits. Springer; 2016. |